Date: Feb 03, 2019
By: Lee I-chia / Staff reporter
The National Health Insurance Administration (NHIA) has reduced reimbursements for
7,470 drugs covered by the National Health Insurance (NHI) and expects to save about NT$5.83 billion (US$189.6 million), it said on Friday.
In an effort to secure financial stability for the NHI by reducing the gap between sale and procurement prices, it introduced a drug expenditure target pilot program in 2013 to adjust pharmaceutical prices on an annual basis, the agency said.
Under the scheme, the agency sets a target for total annual NHI expenditure on drugs and if that exceeds the budget, price adjustments are implemented.
The scheme was revised when it ended in 2016 and a modified three-year pilot program was implemented in 2017 that excludes expenditure for treating HIV infection, hepatitis C, hemophilia and rare diseases. [FULL STORY]